COMP <GO>
TMCI vs OSUR // RSI-14 & 200D SMA MOMENTUM
Treace Medical Concepts Inc. (NASDAQ) VS. OraSure Technologies Inc. (NASDAQ) • 15-METRIC TALLY: TMCI 9
— OSUR 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TMCI
LAST: $4.43 (-12.45%) • MKT CAP: $329.1M
rsi-technicals
62.7
LAST: $3.94 (-3.43%) • MKT CAP: $281.4M
rsi-technicals
57.0
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TMCI VS. OSUR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TMCI | OSUR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.80% | 41.90% | +37.90 | TMCI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.40% | -35.00% | +2.60 | TMCI | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.96% | -18.91% | +9.95 | TMCI | /fcf-yield <GO> |
| Operating Margin | -25.50% | -60.00% | +34.50 | TMCI | /operating-margins <GO> |
| Net Profit Margin | -27.70% | -59.80% | +32.10 | TMCI | /net-margins <GO> |
| Revenue Growth (YoY) | 1.60% | -38.10% | +39.70 | TMCI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.90 | 2.47 | -1.57 | OSUR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 3/9 | +1.00 | TMCI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 62.7 | 57.0 | +5.70 | TMCI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $329.1M | $281.4M | $47.7M | TMCI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TMCI REV | OSUR REV | TMCI GROSS % | OSUR GROSS % | TMCI FCF | OSUR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $212.7M | $115.0M | 79.8% | 41.9% | -$29.5M | -$53.2M |
| FY 2024 | $209.4M | $185.8M | 80.4% | 42.7% | -$48.8M | $23.6M |
| FY 2023 | $187.1M | $405.5M | — | — | -$34.6M | $141.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TMCI // BETA —
OSUR // BETA —